Glenza 40mg Enzalutamide Capsule

Glenza 40mg Enzalutamide Capsule is a prescription anti-cancer medication used in the treatment of prostate cancer, particularly advanced, recurrent, or metastatic forms of the disease. It contains Enzalutamide, an androgen receptor inhibitor that works by blocking the effects of male hormones (androgens) that can promote the growth of prostate cancer cells. By inhibiting androgen signaling, Glenza 40mg Capsule helps slow cancer progression and supports effective disease management. Taken orally under the supervision of an oncology specialist, it may be prescribed alone or in combination with other therapies depending on the patient's condition. Regular monitoring is important during treatment to evaluate effectiveness and manage potential side effects. Patients should use Glenza 40mg Enzalutamide Capsule only as directed by their healthcare provider.